| 1 |
Jatin PS. Cancer of the head and neck（American cancer society atlas of oncology）. London：Bc Decker Inc， 2001：1-4.
|
| 2 |
Warnakulasuriya S， Sutherland G， Scully C. Tobacco， oral cancer， and treatment of dependence. Oral Oncol， 2005，41（3）：244-260.
|
| 3 |
Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest， 2003，111（1）：31-33.
|
| 4 |
Conti-Fine BM， Navaneetham D， Lei S， et al. Neuronal nicotinic receptors in non-neuronal cells：new mediators of tobacco toxicity？ Eur J Pharmacol， 2000，393（1-3）：279-294.
|
| 5 |
Wu XH， Wang HF， Liu YF， et al. Histone adduction with nicotine：A bio-AMS study. Radiocarbon， 1997，39（2）：293-297.
|
| 6 |
Tsurutani J， Castillo SS， Brognard J， et al. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis， 2005，26（7）：1182-1195.
|
| 7 |
Arredondo J， Chernyavsky AI， Jolkovsky DL， et al. Receptormediated tobacco toxicity：cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J，2006，20（12）：2093-2101.
|
| 8 |
Mousa S， Mousa SA. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. J Cell Biochem， 2006，97（6）：1370-1378.
|
| 9 |
Onoda N， Nehmi A， Weiner D， et al. Nicotine affects the signaling of the death pathway， reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck， 2001，23（10）：860-870.
|
| 10 |
Arredondo J， Chernyavsky AI， Grando SA. Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol Ther， 2006，5（5）：511-517.
|
| 11 |
Wright SC， Zhong J， Zheng H， et al. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J， 1993，7（11）：1045-1051.
|
| 12 |
Pignon JP， Bourhis J， Domenge C， et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma：three meta-analyses of updated individual data.MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet， 2000，355（9）：949-955.
|
| 13 |
Tamatani T， Azuma M， Ashida Y， et al. Enhanced radiosensitization and chemosensitization in NF-kappaBsuppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8. Int J Cancer， 2004，108（6）：912-921.
|
| 14 |
Miyashita H， Nitta Y， Mori S， et al. Expression of coppertransporting P-type adenosine triphosphatase （ATP7B） as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. Oral Oncol， 2003，39（2）：157-162.
|
| 15 |
Singh N， Khanna N， Sharma H， et al. Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-erived RT-101 cells. Biochem Biophys Res Commun， 2002，295（1）：24-30.
|
| 16 |
Elbashir SM， Harborth J， Lendeckel W， et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature， 2001，411（4836）：494-498.
|
| 17 |
Carvalho A， Carmena M， Sambade C， et al. Survivin is required for stable checkpoint activation in Taxol-treated HeLa cells. J Cell Sci， 2003，116（14）：2987-2998.
|
| 18 |
Paduano F， Villa R， Pennati M， et al. Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppressionincombinationwith17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells. Mol Cancer Ther， 2006，5（1）：179-186.
|
| 19 |
Lee HJ， Guo HY， Lee SK， et al. Effects of nicotine on proliferation，cell cycle，and differentiation in immortalized and malignant oral keratinocytes. J Oral Pathol Med， 2005，34（7）：436-443.
|
| 20 |
Tanaka C， Uzawa K， Shibahara T， et al. Expression of an inhibitor of apoptosis， survivin， in oral carcinogenesis. J Dent Res， 2003，82（8）：607-611.
|
| 21 |
Lo Muzio L， Farina A， Rubini C， et al. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity.Cancer Lett， 2005，225（1）：27-33.
|
| 22 |
Tamm I， Wang Y， Sausville E， et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas（CD95）， Bax， caspases， and anticancer drugs. Cancer Res，1998，58（23）：5315-5320.
|
| 23 |
Zaffaroni N， Pennati M， Daidone MG. Survivin as a target for new anticancer interventions. J Cell Mol Med， 2005，9（2）：360-372.
|
| 24 |
Ohashi H， Takagi H， Oh H， et al. Phosphatidylinositol 3-kinase/Akt regulates angiotensin Ⅱ-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res， 2004，94（6）：785-793.
|
| 25 |
Kim S， Kang J， Qiao J， et al. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAILmediated apoptosis in neuroblastomas. J Pediatr Surg， 2004，39（4）：516-521.
|
| 26 |
Dasgupta P， Kinkade R， Joshi B， et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A， 2006，103（16）：6332-6337.
|
| 27 |
Jin Z， Gao F， Flagg T， et al. Tobacco-specific nitrosamine 4-（methylnitrosamino）-1-（3-pyridyl）-1-butanonepromotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem， 2004，279（38）：40209-40219.
|
| 28 |
Trombino S， Cesario A， Margaritora S， et al. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells：role of mitogen-activated protein kinase pathway. Cancer Res， 2004，64（1）：135-145.
|
| 29 |
Xin M， Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem， 2005，280（11）：10781-10789.
|